PUBLISHER: Grand View Research | PRODUCT CODE: 1363524
PUBLISHER: Grand View Research | PRODUCT CODE: 1363524
The global respiratory filters market size is expected to reach USD 802.4 million by 2030, registering a CAGR of 5.5% from 2023 to 2030, according to a new study by Grand View Research, Inc.. Growth in the market is driven by the increasing prevalence of chronic respiratory diseases, strategic initiatives by organizations, technological advancements, and the cost-effectiveness of the devices. Moreover, the increased awareness about respiratory health and the importance of preparedness for future respiratory emergencies have highlighted the need for improved respiratory support infrastructure. As a result, governments and healthcare institutions may invest in upgrading and expanding their respiratory device capabilities, thus holding potential growth for the market.
According to the CDC, the incidence of Tuberculosis (TB) (cases per 100,000 population) among Americans increased from 0.71 in 2020 to 0.79 in 2021, while it grew from 11.71 in 2020 to 12.16 in 2021 among non-Americans. Growing number of patients with TB further increases the demand for respiratory care devices used in TB therapy. For instance, during and after TB treatment, respirators, nebulizers, polysomnography devices, BiPAP devices, etc., are frequently utilized, which, in turn, is boosting the demand for respiratory care devices, including respiratory filters. The COVID-19 pandemic has been advantageous for the overall market, and it has had a positive impact on its growth. The demand for some key products, such as ventilators, Continuous Positive Airway Pressure (CPAP) machines, and oxygen concentrators increased by 4-5 times, thereby driving market growth. While the pandemic drove the initial surge in demand, the long-term market outlook for respiratory filters remains positive.